MedTrace Logo

Intradialytic Progressive Resistance Training for Maintenance Haemodialysis Patients

NCT01007838 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2012-01-05

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to investigate the effects of a 12 week progressive resistance training during haemodialysis on muscle quantity and physical functioning in chronic kidney disease patients receiving maintenance haemodialysis.

It is hypothesised, based on previous literature involving similar resistance training protocols in other catabolic conditions, that the resistance training will result in a significant increase in muscle quantity as well a physical function.

Conditions

Interventions

OTHER

Progressive resistance training programme

Progressive resistance training programme using a dialysis specific fitness machine: 80 % of predicted one repetition max, weight lifted will be increased when three sets of ten repetitions can be completed without failure.

OTHER

Sham exercise

Lower body stretching exercise using the easiest rehabilitation elastic Theraband

OTHER

Progressive resistance training

Progressive resistance training programme using a dialysis specific fitness machine: 80 % of predicted one repetition max, weight lifted will be increased when three sets of ten repetitions can be completed without failure.

OTHER

Sham exercise

Lower body stretching exercise using the easiest rehabilitation elastic Theraband

Sponsors & Collaborators

  • Betsi Cadwaladr University Health Board

    collaborator OTHER_GOV

  • Bangor University

    lead OTHER

Principal Investigators

  • Jamie H MacDonald, PhD · Bangor University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2011-10-31
Completion
2011-10-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01007838 on ClinicalTrials.gov